KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Current Leases: 2010-2021

Historic Current Leases for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Dec 2021 value amounting to $719.7 million.

  • Regeneron Pharmaceuticals' Current Leases was N/A to $719.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $719.7 million, marking a year-over-year change of. This contributed to the annual value of $719.7 million for FY2021, which is N/A change from last year.
  • Regeneron Pharmaceuticals' Current Leases amounted to $719.7 million in FY2021, which was up 465.47% from $127.3 million recorded in FY2016.
  • Regeneron Pharmaceuticals' Current Leases' 5-year high stood at $719.7 million during FY2021, with a 5-year trough of $719.7 million in FY2021.
  • For the 1-year period, Regeneron Pharmaceuticals' Current Leases averaged around $719.7 million, with its median value being $719.7 million (2021).